Hyeon-A Kim & Joo-Eun Kim. (2022). Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach. MDPI AG.
Chicago Style (17th ed.) CitationHyeon-A Kim and Joo-Eun Kim. Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach. MDPI AG, 2022.
MLA (9th ed.) CitationHyeon-A Kim and Joo-Eun Kim. Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.